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Thirty-one sheep naturally infected with small ruminant lentiviruses (SRLV) of known genotype (A or B), and
clinically affected with neurological disease, pneumonia or arthritis were used to analyse mannose receptor (MR)
expression (transcript levels) and proviral load in virus target tissues (lung, mammary gland, CNS and carpal joints).
Control sheep were SRLV-seropositive asymptomatic (n= 3), seronegative (n= 3) or with chronic listeriosis,
pseudotuberculosis or parasitic cysts (n= 1 in each case). MR expression and proviral load increased with the
severity of lesions in most analyzed organs of the SRLV infected sheep and was detected in the affected tissue
involved in the corresponding clinical disease (CNS, lung and carpal joint in neurological disease, pneumonia and
arthritis animal groups, respectively). The increased MR expression appeared to be SRLV specific and may have a
role in lentiviral pathogenesis.Introduction, methods and results
Pneumonia and mastitis have been the most common
small ruminant lentivirus (SRLV)-triggered clinical forms
found in Spanish sheep flocks [1], but two disease out-
breaks have been described recently, either targeted to
the CNS (visna), involving meningoencephalitis [2] and
myelitis [3], or causing arthritis, specifically carpal joint
synovitis, together with interstitial mastitis and/or
pneumonia [4,5]. Histopathologically, the different SRLV
disease forms involve lesions with infiltration of macro-
phages and lymphocytes, non-suppurative inflammation
and fibrosis [6]. Virus levels have been positively corre-
lated with lesion severity in terms of proviral load in
blood [7], proviral and viral load in tissues [8] or proviral
load in lungs [9]. In this study, knowing the role of the
mannose receptor (MR) as a cellular receptor for SRLV
in vitro [10], we aimed to investigate in SRLV natural
infections if MR expression was increased in affected
target tissues from animals with the different clinical
forms of the disease and if this putative increase was
related to the presence of infected cells (increased pro-
viral load) and lesions in these tissues, in order to gain* Correspondence: ramses.reina@unavarra.es
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reproduction in any medium, provided the orknowledge on factors involved in the development of
SRLV-induced clinical infection and pathogenesis.
Thirty-one sheep naturally SRLV-infected according to
Elitest (Hyphen Biomed, France), which were also clinic-
ally affected (Table 1), were humanely euthanatized in
compliance with the current European and national (RD
1201/2005) regulations, with the approval of the “Comité
de Ética y Experimentación Animal” of the Universities
of León and Zaragoza and authorization of the
Castilla y León and Aragón Governments for pathology
studies. Sheep were distributed into three groups for
comparative purposes according to clinical manifesta-
tions: a) encephalitis (with non-purulent encephalitis,
myelitis and/or choroiditis/meningitis); b) pneumonia
(affected by interstitial pneumonia and follicular hyper-
plasia in lungs); and c) arthritis (with arthritis in carpal
joints, in the presence/absence of pneumonia and/or
mastitis). Three seropositive asymptomatic and three
seronegative animals, included as controls, did not show
any lesion compatible with SRLV infection. Tissue sam-
ples from lung, mediastinic lymph node, central nervous
system (brain cortex, diencephalon, corpus callosum,
hippocampus, midbrain, cerebellar cortex, pons and
cerebellar peduncles, medulla oblongata, and cervical,
thoracic and lumbar spinal cord), carpal joint and mam-
mary gland were collected post-mortem and stored atLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Histopathological post-mortem observations in SRLV target tissues among groups of animals clinically
affected with encephalitis, pneumonia or arthritis
Tissue
Clinical disease Animal no. CNS Lung Carpal joints Mammary glands
E C ME IP FH A IM
Encephalitis 1 + + +++ - - - +
(n= 15) 2 + - +++ - - - Male
3 + ++ +++ - + - +
4 +++ + - - - - -
5 +++ + +++ - - - -
6 ++ +++ +++ - - - -
7 + +++ - - - - +
8 + ++ - - - - -
9 + ++ - - - - -
10 +++ + ++ - + - +
11 +++ + - - + - -
12 +++ + - - - - +
13 + +++ ++ - + - -
14 +++ + +++ - - - ++
15 +++ + +++ - - - ++
Pneumonia 16 - - - +++ +++ - +
(n= 8) 17 - - - ++ ++ - -
18 - - - + + - -
19 - - - ++ ++ - +
20 - - - + +++ - -
21 - + - ++ +++ - -
22 - - - ++ +++ - +
23 - - - + NA - -
Arthritis 24 - - - +++ ++ +++ -
(n= 8) 25 - - - + - + -
26 - - - + - + ++
27 - - - ++ ++ ++ ++
28 NA NA NA NA NA NA NA
29 - - - + + + ++
30 - - - + +++ + -
31 NA NA NA NA NA NA NA
Signs of lesion were recorded as encephalitis (E), choroiditis (C), myelitis (ME), interstitial pneumonia (IP), follicular hyperplasia (FH), arthritis (A) and interstitial
mastitis (IM). The severity of lesions was scored as (−) absence of lesion, (+) mild, (++) moderate, (+++) severe. NA: Not available.
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formalin and zinc fixative salts (0.5% zinc chloride, 0.5%
zinc acetate in 0.1 M Tris base buffer containing 0.05%
calcium acetate, pH= 7.4) for subsequent staining with
hematoxylin-eosin and examination under light micros-
copy by two different pathologists.
Scoring of histological VMV-related lesions in target
organs were based on previous works [11]. The para-
meters evaluated in lungs were the presence of interstitialpneumonia (IP) as: “-”absent; “+” mild and “++”severe,
and follicular hyperplasia (FH) as: “-”absent; “+”< 2 folli-
cles; “++” 3–6 follicles; “+++” > 6 follicles per 40x•field. In
mammary glands, the interstitial mastitis (IM) was evalu-
ated as in lungs. In carpal joints, the severity of the
arthritis (A) was evaluated as “-“absent; “+” light; “++”
mild and “+++” severe. Lesions of the nervous system
were classified into the previously described categories [2]:
“-”absent; “+” mild, consisting of multifocal small areas of
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cent zones of non-suppurative inflammation, composed of
perivascular cuffs of lymphocytes and macrophages with
limited areas of demyelination; and “+++” severe, charac-
terized by extensive areas of diffuse mononuclear inflam-
mation, with numerous macrophages and malacia.
Tissue samples (10 mg pieces) were disrupted using
the Mikro-Dismembrator U (Sartorius) in AL buffer
(Qiagen) or RLT buffer plus ß-mercaptoethanol for
DNA and RNA extraction, respectively. DNA was
extracted with Qiamp DNA Blood Mini kit (Qiagen) and
RNA with RNeasy Mini Kit (Qiagen). Then RNA was
treated with DNAseI (Sigma) and retrotranscribed to
cDNA (RT-PCR) with SuperScript II (Invitrogen), using
oligo-dT as primers to determine MR expression (tran-
scripts) in tissues by real time PCR as described previ-
ously [10], using ß-actine as housekeeping gene for each
cDNA sample. MR expression values (2-ΔCt × 100) and
proviral load (viral DNA copies/100 ng of DNA; see
below) were compared by non-parametric Wilcoxon test
for related samples and comparisons between groups
were made (non-related samples) by Mann-Whitney’s
test. Within each diseased animal group, real time PCR
results revealed a significantly increased MR expression
in SRLV affected tissues (Figure 1): CNS (p= 0.0145),
lung (p= 0.024) and carpal joint (p= 0.001) in the en-
cephalitis, pneumonia and arthritis groups, respectively.
In line with this, inter-group analysis indicated that,
compared to other animal groups, CNS samples had the
highest MR expression in the encephalitis group
(p= 0.035); and carpal joints had the highest MRapneumoniaencephalitisM
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Figure 1 MR relative expression in SRLV target tissues from animal g
encephalitis), pulmonary disease (pneumonia) or arthritis. Seropositiv
controls. Target tissues were CNS structures (open bars), respiratory tract (g
bars). Data are expressed are expressed as 2- ΔCt  100 ± SE.expression in the arthritic group (p= 0.013). Although
lung and mediastinic lymph node appeared to have the
highest MR expression in the pneumonia group com-
pared to others, differences were only statistically signifi-
cant when this group was compared with the
encephalitis group (p= 0.020). The presence of mastitis
was not evident macroscopically, but in the three groups
(Table 1) there were animals presenting mild or moder-
ate (never severe) SRLV-compatible microscopic lesions
in the mammary gland. MR levels were higher in ani-
mals presenting lesions in this organ (moderate alone or
combined with mild) compared to animals not present-
ing lesions (p= 0.034); similarly in lungs, MR expression
was increased in animals with severe lung lesions in
comparison with those without lesions (p= 0.021).
Induction of MR expression in affected target tissues
appeared to be mediated by SRLV infection, since MR ex-
pression in the SRLV-uninfected animals of the control
group clinically affected with pseudotuberculosis, pulmon-
ary parasitic cysts (both pulmonary pathologies) or chronic
listeriosis (CNS pathology), was low in lung and CNS, re-
spectively, compared with the SRLV-clinically affected ani-
mals (Figure 2). Accordingly, proviral load was measured in
affected tissues to further investigate a possible link
between SRLV infection and MR expression. Specifically,
proviral load was assessed by real time PCR of genomic
DNA as described previously [12], using SYBR Premix Ex
Taq (Takara) and LTR-region specific primers designed for
encephalitis A [13], pneumonia A [14] and arthritis B2
(this work; Fw: TGCTGCTTGCACTTCRGAGTT; Rv:
GGCAG TAAGGCAATCACTCCTT) genotypes to obtainseronegativeseropositive 
asymptomatic
rthritis
roups affected with neurological disease (indicated as
e asymptomatic and seronegative animals were included as
rey bars), carpal joints (dotted bars) and/or mammary gland (squared
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Figure 2 MR expression in CNS structures of animals with
neurological disease caused by SRLV (n=15) or by chronic
listeriosis (n=1) and in respiratory tract (lung and mediastinic
lymph node, ML) of animals affected with SRLV pneumonia
(n=8), pseudotuberculosis (n=1), and lung parasitic cysts
(n=1). Data are expressed as 2- ΔCt × 100 ± SE.
Figure 3 Proviral load (SRLV copy number/100 ng of DNA) in
target tissues (CNS structures (white bars), respiratory tract
(grey bars), carpal joint (dotted bars), and mammary gland
(squared bars) among the clinically affected groups. Proviral
load was quantified by real-time PCR amplifying the LTR region.
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diluted plasmids (pGEM-T Easy, Promega) containing the
LTR region were employed to generate the standard curve
(Ct vs. copy number) and determine sample copy number
values. Plasmid copy number ranged from 1 to 106. Results,
expressed as provirus copy number/100 ng of DNA, indi-
cated that in all the clinically affected groups, the highest
proviral load was detected in lung (Figure 3). When study-
ing other tissues, the results resembled those on MR ex-
pression in that within each particular animal group, the
highest number of copies (proviral load in this case) corre-
sponded to tissues with main lesions, particularly CNS
structures in the encephalitis group (p<0.05), respiratory
tract in the pneumonia group (p<0.05), and carpal joints
for the arthritic group (p<0.02). Also, inter-group compari-
sons revealed an increased (p<0.005) proviral load in CNS
structures of encephalitis-affected animals compared to
other groups, as observed in MR expression. The proviral
load in mammary glands or lungs did not differ between
the three clinically affected groups described in Table 1, but
when animals of these groups were jointly reclassified
attending to lesion degree (null, mild, moderate or severe),
as it was done when assessing MR level differences, notonly the presence or absence of lesions but also the degree
of lesion was significantly associated with proviral load, as
observed in MR expression. For example, mammary gland
proviral load was increased either in animals with moderate
lesions in this organ compared to those with mild lesions
(p=0.016) or in animals with lesions in this organ com-
pared to those without lesions (p=0.003). In line with this,
lung proviral load was increased in lung with severe
(p=0.002) or with any degree of lesion (p=0.003) com-
pared to lung without lesions. Since different levels of lesion
severity were recorded in target organs, all MR expression
and proviral load values were plotted according to these
levels of severity (Table 1). In the case of lung or CNS,
where more than one sign were evaluated per organ, only
one, FH and E respectively, were considered as represen-
tative of the overall lesion degree in that specific organ
(Figure 4). Severe lesions were mainly (7 out of 9 cases)
accompanied by increased MR expression and increased
proviral loads. There were organs presenting moderate
lesions which also showed both, increased MR and pro-
viral load values, strongly suggesting intermediate steps in
the process. Although there were exceptions, two organs
with a high proviral load, low-to-very low MR expression
and no lesions, and one organ with low MR expression
and viral load but severe lesions (Figure 4).
Discussion
MR is one of the putative SRLV receptors and, although
MR transcripts have been found in vitro in sheep mono-
cytes/macrophages and synovial membrane fibroblasts
[10], the levels of MR transcripts in SRLV target tissues
from natural clinical infections have not been assessed
so far and it is unknown if MR could play a role in
SRLV pathogenesis. This work demonstrates that MR
Figure 4 Relationship between MR relative expression (2-ΔCt 
100) and proviral load (SRLV copy number/100 ng) in target
tissues (lung, encephalon, carpal joint and mammary gland)
according to the severity of lesions (no lesion (open squares),
mild (open triangles), moderate (open circles), or severe (solid
circles)) detected in each tissue by histopathological analysis.
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increased in tissues affected by clinical A or B SRLV
infections presenting different disease forms (CNS in the
neurological, lung in the pulmonary and carpal joint in
the arthritic form), and that the increase in both of them
is related to the severity of lesions, strongly suggesting a
role of MR expression in SRLV pathogenesis, independ-
ently of the disease form presented by the animal.
Increased proviral load in affected organs was expected
according to previous SRLV results [7–9]. In addition,
the increased MR expression observed in heavily
infected body sites would be expected, since the virus
may enter the cell via MR [10,15] and cells like macro-
phages with enhanced MR expression may not favour
Th1 responses (as observed in mice; [16]), which would
be necessary for development and differentiation of
cytotoxic cells against virus infected targets. Thus, MR-
expressing macrophages may enhance clinical disease
development.
The scattered distribution of mammary gland lesions
into the three clinically affected study groups together
with the absence of severe mastitis lesions, may explain
the lack of significant differences in MR expression and
viral DNA load in mammary gland between the three
clinically affected study groups. This is in line with the
existence of significant differences in MR expression and
proviral load demonstrated between animal groups when
animals were instead classified according to lesionseverity. Comparative analysis of lesions distribution
according to lesion degree, levels of MR and proviral
load further indicated a positive association between
these three parameters. Interestingly, the organ found
with no lesion but high proviral load and very low MR
expression was the lung from animal 14, which pre-
sented severe lesions in other organs (Table 1), indicat-
ing that persistent infection was already established and
clinical manifestations would appear progressively in this
target organ. Similarly, the absence of lesion found in an
organ (lung) with high MR/proviral load corresponded
to animal number 12 that showed another type of lesion
(IP), suggesting an incipient stage in the development of
clinical signs in the lung of this animal. Another inter-
esting organ was that which presented severe lesions but
low MR expression and proviral load. Analysis of all the
tissues under study from the corresponding animal
(number 5) indicated always low MR and proviral load,
suggesting a possible role for the host’s genetic back-
ground. As revealed by proviral load values, infected
cells appeared to be more abundant in the lungs of all
groups, which was expected since lung-associated cells
may represent one of the main infection routes [17]
favouring viral replication in alveolar macrophages [18].
The identification of MR as a main cell entry pathway
involved in pathogenesis opens possibilities in entry-
blocking treatment against SRLV and new insights into
SRLV control beyond diagnosis and immunization.
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